$BKKT

Baes Nicholas sold $12K of BKKT

Baes Nicholas (Chief Operating Officer) sold 1,562 shares of Bakkt, Inc. (BKKT) at $7.93 on 2026-06-25.

Original reporting
SEC EDGAR · Baes Nicholas
Published Jun 29, 2026, 10:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 29, 2026, 10:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BKKT
Neutral
medium confidence
Mentioned
$BKKT
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BKKTNeutralLow
01

Why it matters

This provides a datapoint on insider behavior but does not include new business, financial, or regulatory information that would change valuation assumptions.

02

Market read

Traders may note insider selling as a minor sentiment input, but there is no fundamental catalyst in the text.

03

What to watch

No 10b5-1 plan is stated, but the article provides no context on prior grants, total compensation, or whether other insiders are buying/selling concurrently.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-29 after-hours; reflects sale executed 2026-06-25.

Background

The article is an SEC Form 4 insider transaction disclosure for Bakkt, Inc.

Company-level read

Ticker impact

$BKKTNeutralMedium confidence
Context

SEC Form 4 shows COO Nicholas Baes sold 1,562 shares of Bakkt at $7.93 on 2026-06-25, disclosing direct insider selling.

Expected impact

Low near-term impact; any effect is likely sentiment-only and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and a modest dollar value, which typically does not drive sustained repricing without accompanying company news.

Market effects

Minimal—single-company insider sale without operational/regulatory updates.

None indicated.

None indicated.

Counterpoint

The sale may be for diversification/tax/compensation liquidity rather than a bearish view, especially given the lack of any accompanying negative company-specific disclosure.

Key entities

  • Bakkt, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Nicholas Baes

    Chief Operating Officer who sold shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BKKTMedAI 8/10

Bakkt (BKKT) Q2 2026 Earnings Call Transcript

Bakkt (BKKT) reported Q2 2026 revenue of $170.1 million, down 70% from $568.1 million, citing client transitions and weaker digital asset trading volumes. GAAP net income was $80.8 million, driven mainly by a $98.5 million non-cash gain from Transchem warrants. Total transacting volume was $168.8 million; management reiterated an EBITDA breakeven target in Q4 2026.

$BKKTMed

Bakkt Inc (BKKT) (Q2 2026) Earnings Call Highlights: Strong GAAP Net Income

Bakkt’s CEO Akshay Naheta said the company expects adjusted EBITDA break-even in Q4 2026, without a specific date, citing execution and client activations. Management discussed take rates, cross-border margins, and reaffirmed a 2026 TTV target of about $2.5 billion. The firm outlined post-DTR acquisition progress and Bakkt Agent MAU target of ~25,000 by year-end 2026.

$BKKTMed

Bakkt, Inc. (BKKT): Results of Operations and Financial Condition

Bakkt, Inc. (BKKT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Bakkt Reports Second Quarter 2026 Results - GAAP net income of $80.8 million, or $1.96 per basic and $1.94 per diluted share - Six commercial offerings live across Bakkt Markets; Total Transacting Volume (“TTV”) of $168.8 million in Q2, including payments volume generated on acqu